Helicobacter pylori and autoimmune diseases

Biomedicine and Pharmacotherapy

Volumn 67, Issue 4, 2013, Pages 347-349

  Faria, Carolina ^a   Zakout, Raed ^a   Araújo, Mascarenhas ^a  

^a HOSPITAL PROF DOUTOR FERNANDO FONSECA   (Portugal)

Author keywords

Autoimmune diseases; Eradication therapy; Helicobacter pylori; Molecular mimicry

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; AUTOIMMUNE PANCREATITIS; AUTOIMMUNE THYROID DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR MIMICRY; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; STOOL ANTIGEN TEST; THYROID DISEASE; UREA BREATH TEST;

AUTOIMMUNE DISEASES; BREATH TESTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MOLECULAR MIMICRY; UREA;

EID: 84876918195     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.09.015     Document Type: Review

References (53)

1. Marshall B.J., Warren R. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983, 8336:1273-1275.
2. Bruce M.G., Maaroos H.I. Epidemiology of Helicobacter pylori infection. Helicobacter 2008, 13:1-6.
3. Atherton J.C. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006, 1:63-96.
4. Guru T., Philip A., Dasanu C., Baker W. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. J Pancreas 2011, 12:26-31.
5. Gasbarrini A., Franceschi F Autoimmune diseases and Helicobacter pylori infection. Biomed Pharmacother 1999, 53:223-226.
6. Provan D., Stasi R., Newland A.C., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.
7. Neunert C., Lim W., Crowther M., Cohen A., Solberg L., Crowther A. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011, 117:4190-4207.
8. Stasi R., Rossi Z., Stipa E., Amadori S., Newland A.C., Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005, 118:414-419.
9. Ahn E.R., Tiede M.P., Jy W., Bidot C.J., Fontana V., Ahn Y.S. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol 2006, 116:19-24.
10. Suvajdzic N., Stankovic B., Artiko V., et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura. Platelets 2006, 17:227-230.
11. Gasbarrini A., Franceschi F., Tartaglione R., Landolfi R., Pola P., Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998, 352:878.
12. Sato R., Murakami K., Watanabe K., et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004, 164:1904-1907.
13. Kohda K., Kuga T., Kogawa K., et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002, 118:584-588.
14. Emilia G., Luppi M., Zucchini P., et al. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007, 110:3833-3841.
15. Suzuki T., Matsushima M., Masui A., et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 2005, 100:1265-1270.
16. Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura. A systematic review. Blood 2009, 113:1231-1240.
17. Franchini M., Cruciani M., Mengoli C., Pizzolo G., Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J Antimicrob Chemother 2007, 60:237-246.
18. Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura?. A review of the literature. Am J Hematol 2005, 78:142-150.
19. Arnold M., Bernotas A., Nazi I., Stasi R., Kuwana M., et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica 2009, 94:850-856.
20. Franceschi F., Christodoulides N., Kroll M.H., Genta R.M. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 2004, 140:766-767.
21. Takahashi T., Yujiri T., Shinohara K., et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004, 124:91-96.
22. Ko G.H., et al. Monoclonal antibodies against Helicobacter cross-react with human tissue. Helicobacter 1997, 9:231-233.
23. Semple J.W., Aslam R., Kim M., Speck E.R., Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood 2007, 109:4803-4805.
24. Larizza D., et al. Helicobacter pylori infection and autoimmune thyroid disease in young patients. JCEM 2006, 91:176-179.
25. De Luis D.A., Varela C., de La Calle H., Canton R., de Argila C.M., San Roman A.L., et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998, 26:259-263.
26. Figura N., Di Cairano G., Lore F., Guarino E., Gragnoli A., Cataldo D., et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999, 50:817-826.
27. Sterzl I., Hrda1 P., Matucha1 P., Cefovskä J., Zamrazil V. Anti-Helicobacter pylori, antithyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol 2008, 57:135-141.
28. Bertalot G., Montresor G., Tampieri M., Spasiano A., Pedroni M., Milanesi B., et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol 2004, 61:650-652.
29. Tomasi P.A., Dore M.P., Fanciulli G., Sanciu F., Realdi G., Delitala G. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?. Dig Dis Sci 2005, 50:385-388.
30. Franceschi F., Satta M.A., Mentella M.C., Penland R., Candelli M., Grillo R.L., et al. Helicobacter pylori infection in patients with Hashimoto's thyroiditis. Helicobacter 2004, 9:369.
31. Gasbarrini A., Franceschi F., Cammarota G., Pola P., Gasbarrini G. Vascular and immunological disorders associated with Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1998, 30:115-118.
32. Gasbarrini A., Serricchio M., Tondi P., Gasbarrini G., Pola P. Association of Helicobacter pylori infection with primary Raynaud phenomenon. Lancet 1996, 348:966-967.
33. Gasbarrini A., Massari I., Serricchio M., Tondi P., De Luca A., Franceschi F., et al. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998, 43:1641-1645.
34. Csiki Z., Gäl I., Sebesi J., Szegedi G. Raynaud syndrome and eradication of Helicobacter pylori. Hung Med J 2001, 141:2827-2829.
35. Yoshida K., Toki F., Takeuchi T., et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40:1561-1568.
36. Kountouras J., Zavos C., Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 2005, 9:196-207.
37. Akihiro S., Kenji S., Hideaki H., Hiroshi U., Mana F., Naoshi N., et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc 2004, 99:506-511.
38. Guarneri F., Guarneri C., Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?. J Cell Mol Med 2005, 9:741-744.
39. Frulloni L., Lunardi C., Simone R., Dolcino M., Scattolini C., Falconi M., et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009, 361:2135-2142.
40. Whittingham S., Mackay I.R. Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems. Int Rev Immunol 2005, 24:1-29.
41. Valle J., Kekki M., Sipponen P., Ihamäki T., Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996, 31:546-550.
42. D'Elios M.M., Appelmelk B.J., Amedei A., Bergman M.P., Del Prete G. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 2004, 10:316-323.
43. Kuipers E.J., Uyterlinde A.M., Pena A.S., et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995, 345:1525-1528.
44. Lahner E., Aniballe B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 2009, 15:5121-5128.
45. Bergman M.P., Vandenbroucke-Grauls C.M., Appelmelk B.J., D'Elios M.M., Amedei A., Azzurri A., et al. The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol 2005, 24:63-91.
46. Vanella L., Lahner E., Bordi C., Pilozzi E., Di Giulio E., Corleto V., et al. Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Dig Liver Dis 2011, 43:295-299.
47. Annibale B., Rosaria M., D'ambra G., Caruana P., Bordi C., Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000, 14:625-634.
48. Annibale B., Negrini R., Caruana P., Lahner E., Grossi C., Bordi C., et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 2001, 6:225-233.
49. Annibale B., Lahner E., Negrini R., Baccini F., Bordi C., Monarca B., et al. Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol 2005, 11:5351-5357.
50. Pérez-Pérez G.I. Role of Helicobacter pylori infection in the development of pernicious anemia. Clin Infect Dis 1997, 25:1020-1022.
51. Kokkola A., Rautelin H., Puolakkainen P., Sipponen P., Farkkila M., Haapiainen R., et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 2000, 35:138-141.
52. Karnes W.E., Samloff I.M., Siurala M., Kekki M., Sipponen P., Kim S.W., et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991, 101:167-174.
53. Mini R., Annibale B., Lahner E., Bernardini G., Figura N., Santucci A. Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem 2006, 52:220-226.